The growing interest in effective weight management has spurred considerable research into groundbreaking treatments. Recently , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor activator , has demonstrated promising results in patient trials, implying potential for significant weight loss . As a result , several individ